Key Programs	Indication	Preclinical	Phase I	Phase II	Phase III/Pivotal	FDA Approval
VIREX (diagnostic) At Home Diagnostic 60.2%

Key Programs (Indication)	Phase
VIREX (diagnostic) PH III